Literature DB >> 7913719

Structure and organization of the human transglutaminase 3 gene: evolutionary relationship to the transglutaminase family.

I G Kim1, S C Lee, J H Lee, J M Yang, S I Chung, P M Steinert.   

Abstract

The human haploid genome contains a family of at least five different transglutaminases that are differentially expressed in time- and tissue-specific ways. Of these, transglutaminase 3 (TGase3) is unusual in that it is a pro-enzyme requiring activation by proteolysis. To date it is known to be expressed only in terminally differentiating epidermal and hair follicle keratinocytes. In this paper we show that it is encoded by a gene (TGM3) of 42.8 kbp containing 13 exons. In the course of isolation of genomic clones for the TGM3 gene, we also found clones encoding the widely expressed tissue or TGase2 enzyme, perhaps due to high degrees of sequence homology. The structure of the TGM2 gene has not yet been reported. Our incomplete data suggest its exon/intron organization is very similar to that of TGM3. Although the common intron splice points of all members of the transglutaminase gene family have been conserved, the TGM3 and TGM2 genes, and the gene for the subplasma membrane transglutaminase-like protein band 4.2, lack two introns found in the TGM1 and factor XIIIa genes, and the exact intron splice point of another intron is shifted with respect to that of the TGM1 and factor XIIIa genes. Based on sequence homologies and gene structures, the data support a phylogenic tree in which the TGM2 and TGM3 genes belong on a branch distinct from other transglutaminases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913719     DOI: 10.1111/1523-1747.ep12392470

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping.

Authors:  S Chavanas; C Garner; C Bodemer; M Ali; D H Teillac; J Wilkinson; J L Bonafé; M Paradisi; D P Kelsell; S i Ansai; Y Mitsuhashi; M Larrègue; I M Leigh; J I Harper; A Taïeb; Y d Prost; L R Cardon; A Hovnanian
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.

Authors:  Wei Liu; Zai-Cheng Yu; Wen-Feng Cao; Fang Ding; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase.

Authors:  H J Dubbink; N S Verkaik; P W Faber; J Trapman; F H Schröder; J C Romijn
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

Review 4.  TIG3: a regulator of type I transglutaminase activity in epidermis.

Authors:  Richard L Eckert; Michael T Sturniolo; Ralph Jans; Catherine A Kraft; Haibing Jiang; Ellen A Rorke
Journal:  Amino Acids       Date:  2008-07-09       Impact factor: 3.520

5.  Replication of linkage at chromosome 20p13 and identification of suggestive sex-differential risk loci for autism spectrum disorder.

Authors:  Donna M Werling; Jennifer K Lowe; Rui Luo; Rita M Cantor; Daniel H Geschwind
Journal:  Mol Autism       Date:  2014-02-17       Impact factor: 7.509

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.